CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript

CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.1669, expectations were $-0.03. CytomX Therapeutics, Inc.

Keep Reading →